BBNX - Beta Bionics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.00
DETAILS
HIGH:
$22.00
LOW:
$19.00
MEDIAN:
$22.00
CONSENSUS:
$21.00
UPSIDE:
6.49%
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 32.0 | 27.6 | 32.1 | 27.3 | 23.2 | 17.6 | 20.4 | 16.7 | 15.0 | 12.9 | 8.3 | 3.1 |
| Cost of Revenue | 13.1 | 11.2 | 13.2 | 12.1 | 10.7 | 8.7 | 8.8 | 7.8 | 7.0 | 5.7 | 3.3 | 1.9 |
| Gross Profit | 18.9 | 16.4 | 18.9 | 15.1 | 12.5 | 9.0 | 11.7 | 8.9 | 8.1 | 7.2 | 5.1 | 1.2 |
| Operating Expenses | ||||||||||||
| R&D Expenses | 10.2 | 10.4 | 10.1 | 8.2 | 8.9 | 7.6 | 9.2 | 5.1 | 6.3 | 5.5 | 4.5 | 3.9 |
| SG&A Expenses | 34.2 | 30.4 | 24.9 | 24.0 | 23.5 | 20.0 | 15.5 | 14.8 | 13.5 | 11.2 | 9.0 | 6.2 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 44.5 | 40.7 | 35.1 | 32.2 | 32.4 | 27.6 | 24.7 | 19.9 | 19.9 | 16.7 | 13.4 | 10.0 |
| Operating Income | ||||||||||||
| Operating Income | (25.6) | (24.3) | (16.1) | (17.0) | (19.9) | (18.6) | (13.0) | (11.0) | (11.8) | (9.5) | (8.4) | (8.8) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 2.2 | 2.4 | 2.7 | 2.8 | 3.0 | 2.4 | 1.0 | 0.8 | 1.0 | 1.1 | 1.3 | 0.4 |
| Profitability | ||||||||||||
| EBITDA | (24.5) | (21.2) | (12.5) | (13.5) | (16.2) | (28.1) | (17.6) | (9.4) | (13.9) | (11.9) | (18.6) | (8.4) |
| EBIT | (25.6) | (21.9) | (13.5) | (14.2) | (16.9) | (28.7) | (18.1) | (9.7) | (14.5) | (12.4) | (18.8) | (8.7) |
| Income Before Tax | (23.4) | (21.9) | (13.5) | (14.2) | (16.9) | (28.7) | (18.1) | (9.7) | (14.5) | (12.4) | (18.8) | (8.7) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (23.4) | (21.9) | (13.5) | (14.2) | (16.9) | (28.7) | (18.1) | (9.7) | (14.5) | (12.4) | (18.8) | (8.7) |
| Per Share Data | ||||||||||||
| EPS (Basic) | -0.53 | -0.49 | -0.33 | -0.33 | -0.39 | -0.66 | -0.42 | -0.23 | -0.34 | -0.29 | -0.44 | -0.20 |
| EPS (Diluted) | -0.53 | -0.49 | -0.33 | -0.33 | -0.39 | -0.66 | -0.42 | -0.23 | -0.34 | -0.29 | -0.44 | -0.20 |
| Shares Outstanding | 44.5 | 44.4 | 40.5 | 43.6 | 43.4 | 43.1 | 42.9 | 42.9 | 42.9 | 43.3 | 42.9 | 42.9 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 44.3 | 30.2 | 31.6 | 38.5 | 35.1 | 42.5 | 30.4 | 17.5 | 96.7 | 26.6 |
| Short-Term Investments | 136.2 | 169.3 | 187.5 | 190.2 | 214.6 | 189.0 | 73.1 | 43.4 | 0 | 70.2 |
| Net Receivables | 20.0 | 17.9 | 19.9 | 14.3 | 13.4 | 11.0 | 12.0 | 7.5 | 0 | 4.4 |
| Inventory | 23.9 | 23.7 | 21.7 | 20.4 | 17.3 | 15.7 | 13.3 | 11.3 | 0 | 1.2 |
| Other Current Assets | 6.7 | 0.4 | 0.1 | 0.3 | 0.3 | 0.3 | 1.1 | 0.3 | (96.7) | 0.3 |
| Total Current Assets | 231.0 | 248.0 | 267.9 | 270.0 | 286.1 | 261.9 | 132.9 | 82.6 | 0 | 103.6 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 16.6 | 16.4 | 15.2 | 14.4 | 12.5 | 11.9 | 11.4 | 11.0 | 0 | 6.2 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 44.6 | 39.9 | 45.4 | 45.3 | 31.1 | 64.0 | 0 | 0.1 | 0 | 0.1 |
| Other Non-Current Assets | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 5.3 | 3.2 | 0 | 0.1 |
| Total Non-Current Assets | 61.4 | 56.4 | 60.8 | 60.0 | 43.9 | 76.1 | 16.7 | 14.4 | 0 | 6.4 |
| Total Assets | 292.4 | 304.4 | 328.7 | 330.0 | 330.0 | 338.0 | 149.6 | 96.9 | 0 | 110.0 |
| Current Liabilities | ||||||||||
| Account Payables | 5.4 | 2.3 | 5.0 | 4.5 | 3.4 | 3.5 | 2.9 | 2.8 | 0 | 1.2 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.4 | 0 | 1.2 |
| Deferred Revenue | 1.9 | 1.7 | 1.6 | 1.3 | 1.1 | 0.9 | 0.9 | 0.6 | 0 | 0.1 |
| Other Current Liabilities | 17.2 | 8.3 | 14.6 | 12.7 | 9.4 | 7.3 | 10.9 | 5.0 | 0 | 2.7 |
| Total Current Liabilities | 26.0 | 23.2 | 30.9 | 25.4 | 19.5 | 16.5 | 21.1 | 17.9 | 0 | 10.6 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.6 | 1.6 | 1.5 | 1.2 | 1.0 | (0.0) | 44.9 | 38.9 | (58.6) | 37.6 |
| Total Non-Current Liabilities | 10.0 | 10.0 | 10.2 | 9.9 | 8.8 | 7.8 | 52.5 | 46.2 | (58.6) | 40.8 |
| Total Liabilities | 36.0 | 33.2 | 41.1 | 35.3 | 28.3 | 24.3 | 73.6 | 64.1 | (58.6) | 51.4 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | (415.2) | (391.8) | (369.9) | (356.5) | (342.3) | (325.4) | (296.7) | (278.6) | 0 | (229.7) |
| Accumulated Other Comprehensive Income | (0.4) | (0.1) | 0.4 | 0.4 | 0.1 | 0.2 | 0.1 | 0.1 | (203.1) | 0.1 |
| Total Stockholders' Equity | 256.4 | 271.2 | 287.6 | 294.8 | 301.6 | 313.8 | 76.0 | 32.9 | 58.6 | 58.6 |
| Total Liabilities & Equity | 292.4 | 304.4 | 328.7 | 330.0 | 330.0 | 338.0 | 149.6 | 96.9 | 0 | 110.0 |
| Debt Metrics | ||||||||||
| Total Debt | 6.5 | 6.9 | 7.3 | 7.7 | 6.7 | 7.0 | 7.3 | 7.3 | 0 | 4.2 |
| Net Debt | (37.8) | (23.3) | (24.3) | (30.8) | (28.4) | (35.5) | (23.2) | (10.2) | (96.7) | (22.3) |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | (23.4) | (21.9) | (13.5) | (14.2) | (16.9) | (28.7) | (18.1) | (9.7) | (14.5) | (12.4) | (18.8) | (8.7) |
| Depreciation & Amortization | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.5 | 0 |
| Stock-Based Compensation | 7.0 | 5.4 | 4.3 | 4.5 | 4.8 | 2.8 | 1.6 | 2.0 | 1.5 | 1.4 | 1.6 | 1.3 |
| Change in Working Capital | 0.5 | (8.2) | (1.3) | 0.3 | (1.5) | (6.5) | (3.2) | (1.7) | (2.7) | (4.9) | (0.6) | 0 |
| Other Non-Cash Items | 0.1 | (0.1) | 0.9 | 0.0 | (0.7) | 11.7 | 5.0 | (0.8) | 2.8 | 3.3 | 10.9 | 7.4 |
| Operating Cash Flow | (14.6) | (23.8) | (8.6) | (8.7) | (13.6) | (20.0) | (14.3) | (9.6) | (12.2) | (12.1) | (6.3) | 0 |
| Investing Activities | ||||||||||||
| Capital Expenditure | (1.0) | (1.4) | (1.9) | (1.3) | (1.8) | (0.3) | (0.6) | (1.9) | (0.5) | (0.4) | (0.3) | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (20.0) | (24.8) | (45.4) | (60.2) | (15.0) | (206.8) | (45.1) | (6.8) | (20.2) | 0 | (69.3) | 0 |
| Sales/Maturities of Investments | 48 | 48 | 48 | 71 | 23 | 28 | 16 | 24 | 24 | 8 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 |
| Investing Cash Flow | 26.9 | 21.8 | 0.7 | 9.5 | 6.2 | (179.1) | (29.7) | 15.2 | 3.3 | 7.6 | (69.6) | 0 |
| Financing Activities | ||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | (2.8) | (1.2) | (0.1) | 0.0 | 0.0 | 0 |
| Financing Cash Flow | 1.8 | 0.6 | 1.1 | 2.7 | 0.0 | 211.1 | 56.9 | (1.2) | (0.1) | 0.0 | 0.0 | 0 |
| Cash Position | ||||||||||||
| Net Change in Cash | 14.1 | (1.4) | (6.9) | 3.4 | (7.4) | 12.0 | 13.0 | 4.5 | (9.0) | (4.5) | (75.9) | 0 |
| Cash at Beginning | 30.3 | 31.7 | 38.6 | 35.2 | 42.6 | 30.5 | 17.6 | 13.1 | 22.2 | 26.7 | 102.6 | 0 |
| Cash at End | 44.4 | 30.3 | 31.7 | 38.6 | 35.2 | 42.6 | 30.5 | 17.6 | 13.1 | 22.2 | 26.7 | 0 |
| Free Cash Flow | (15.7) | (25.2) | (10.5) | (10.0) | (15.4) | (20.3) | (14.8) | (11.5) | (12.7) | (12.6) | (6.7) | 0 |
| Key Metrics | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 32.0 | 27.6 | 32.1 | 27.3 | 23.2 | 17.6 | 20.4 | 16.7 | 15.0 | 12.9 | 8.3 | 3.1 |
| Gross Profit | 18.9 | 16.4 | 18.9 | 15.1 | 12.5 | 9.0 | 11.7 | 8.9 | 8.1 | 7.2 | 5.1 | 1.2 |
| Operating Income | (25.6) | (24.3) | (16.1) | (17.0) | (19.9) | (18.6) | (13.0) | (11.0) | (11.8) | (9.5) | (8.4) | (8.8) |
| Net Income | (23.4) | (21.9) | (13.5) | (14.2) | (16.9) | (28.7) | (18.1) | (9.7) | (14.5) | (12.4) | (18.8) | (8.7) |
| EPS (Diluted) | -0.53 | -0.49 | -0.33 | -0.33 | -0.39 | -0.66 | -0.42 | -0.23 | -0.34 | -0.29 | -0.44 | -0.20 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 44.3 | 30.2 | 31.6 | 38.5 | 35.1 | 42.5 | 30.4 | 17.5 | 96.7 | 26.6 | ||
| Total Assets | 292.4 | 304.4 | 328.7 | 330.0 | 330.0 | 338.0 | 149.6 | 96.9 | 0 | 110.0 | ||
| Total Debt | 6.5 | 6.9 | 7.3 | 7.7 | 6.7 | 7.0 | 7.3 | 7.3 | 0 | 4.2 | ||
| Stockholders' Equity | 256.4 | 271.2 | 287.6 | 294.8 | 301.6 | 313.8 | 76.0 | 32.9 | 58.6 | 58.6 | ||
| Cash Flow | ||||||||||||
| Operating Cash Flow | (14.6) | (23.8) | (8.6) | (8.7) | (13.6) | (20.0) | (14.3) | (9.6) | (12.2) | (12.1) | (6.3) | 0 |
| Capital Expenditure | (1.0) | (1.4) | (1.9) | (1.3) | (1.8) | (0.3) | (0.6) | (1.9) | (0.5) | (0.4) | (0.3) | 0 |
| Free Cash Flow | (15.7) | (25.2) | (10.5) | (10.0) | (15.4) | (20.3) | (14.8) | (11.5) | (12.7) | (12.6) | (6.7) | 0 |